Detalhe da pesquisa
1.
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming.
Curr Treat Options Oncol;
24(8): 1088-1101, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37296367
2.
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
Br J Cancer;
124(3): 587-594, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33154570
3.
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
Int J Cancer;
142(5): 1047-1055, 2018 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29047142
4.
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.
J Cancer Res Clin Oncol;
149(5): 1905-1915, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35796778
5.
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
J Cancer Res Clin Oncol;
146(8): 2077-2087, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32561975